Attitudes towards COVID-19 Booster Vaccines, Vaccine Preferences, Child Immunization, and Recent Issues in Vaccination among University Students in Jordan

Although COVID-19 vaccines have been available in Jordan for more than a year, Jordan suffers from a low vaccination rate. The aim of this study was to explore attitudes towards recent issues in vaccination among university students in Jordan. We adopted a cross sectional study design using an online questionnaire distributed in a Jordanian university with a medical school chosen at random. The survey asked about COVID-19 vaccine preferences, factors affecting COVID-19 vaccine preferences, child vaccination, and booster vaccines. A total of 417 students completed the survey. Most respondents (54.7%) preferred the Pfizer vaccine, and 6.2% refused to take any vaccine. Pfizer’s efficacy against new strains is a main factor in preferring Pfizer over other vaccines (p < 0.01). Most respondents (71%) believed that vaccination is crucial to prevent COVID-19 surges from new COVID-19 strains, while 44.6% of respondents believed that children should be included in vaccination campaigns, and 70% believed that booster vaccines required more studies to prove their efficacy. Students had mixed attitudes towards many recent issues concerning COVID-19 vaccination. Studying these factors and attitudes in more depth and in different populations can pave the way towards improving vaccination rates worldwide.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:10

Enthalten in:

Vaccines - 10(2022), 8 vom: 04. Aug.

Sprache:

Englisch

Beteiligte Personen:

Ryalat, Soukaina [VerfasserIn]
Alduraidi, Hamza [VerfasserIn]
Al-Ryalat, Saif Aldeen [VerfasserIn]
Alzu'bi, Marah [VerfasserIn]
Alzyoud, Muntaser [VerfasserIn]
Odeh, Nada [VerfasserIn]
Alrawabdeh, Jawad [VerfasserIn]

Links:

Volltext

Themen:

Booster vaccines
COVID-19
Child immunization
Journal Article

Anmerkungen:

Date Revised 08.03.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/vaccines10081258

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM345345401